BPC-157/TB500
BPC-157/TB-500 is a dual-compound research blend combining a synthetic 15-amino acid gastric peptide fragment with a synthetic analog of Thymosin Beta-4, a 43-amino acid actin-sequestering protein. Together these compounds engage complementary signaling pathways allowing researchers to examine tissue repair mechanisms and actin cytoskeletal dynamics in controlled laboratory models. Supplied as a lyophilized powder in a 3mL vial, it is intended exclusively for in vitro laboratory research by qualified scientific personnel.
This combination has been utilized in preclinical studies examining growth factor receptor signaling, angiogenesis pathway activity, actin polymerization dynamics, gut epithelial cell function, and nitric oxide pathway interactions — independent of the broader biological effects associated with endogenous BPC and Thymosin Beta-4 activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amounts: 6 mg BPC-157 + 6 mg TB-500 per vial
- Purity: ≥ 98% (HPLC tested)
- BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids)
- Molecular Formula: C₆₂H₉₈N₁₆O₂₂
- Molecular Weight: ~1419.5 g/mol
- TB-500 Sequence (Thymosin Beta-4 fragment 17–23): Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Lys-Thr-Glu-Thr (43 amino acids)
- Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
- Molecular Weight: ~4963 Da
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
